Share-based Payment Arrangement, Expense of Pulmatrix, Inc. from 30 Jun 2013 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Pulmatrix, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2013 to 30 Sep 2025.
  • Pulmatrix, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $6,000, a 97% decline year-over-year.
  • Pulmatrix, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $33,000, a 95% decline year-over-year.
  • Pulmatrix, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $511,000, a 46% decline from 2023.
  • Pulmatrix, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $954,000, a 14% decline from 2022.
  • Pulmatrix, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1,114,000, a 3.8% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Pulmatrix, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $33,000 $6,000 -$191,000 -97% 01 Jul 2025 30 Sep 2025 10-Q 16 Oct 2025 2025 Q3
Q2 2025 $224,000 $6,000 -$97,000 -94% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $321,000 $8,000 -$190,000 -96% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $511,000 $13,000 -$184,000 -93% 01 Oct 2024 31 Dec 2024 10-K 21 Mar 2025 2024 FY
Q3 2024 $695,000 $197,000 -$9,000 -4.4% 01 Jul 2024 30 Sep 2024 10-Q 16 Oct 2025 2025 Q3
Q2 2024 $704,000 $103,000 -$152,000 -60% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 $856,000 $198,000 -$98,000 -33% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 $954,000 $197,000 -$82,000 -29% 01 Oct 2023 31 Dec 2023 10-K 21 Mar 2025 2024 FY
Q3 2023 $1,036,000 $206,000 -$71,000 -26% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024 2024 Q3
Q2 2023 $1,107,000 $255,000 -$22,000 -7.9% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $1,129,000 $296,000 +$15,000 +5.3% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q4 2022 $1,114,000 $279,000 +$32,000 +13% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $1,082,000 $277,000 -$7,000 -2.5% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $1,089,000 $277,000 -$22,000 -7.4% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $1,111,000 $281,000 -$47,000 -14% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q4 2021 $1,158,000 $247,000 +$1,000 +0.41% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $1,157,000 $284,000 -$19,000 -6.3% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $1,176,000 $299,000 +$33,000 +12% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022 2022 Q2
Q1 2021 $1,143,000 $328,000 -$15,000 -4.4% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $1,158,000 $246,000 01 Oct 2020 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q3 2020 $303,000 +$118,000 +64% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $266,000 -$825,000 -76% 01 Apr 2020 30 Jun 2020 10-Q 10 Aug 2021 2021 Q2
Q1 2020 $343,000 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021 2021 Q1
Q3 2019 $185,000 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 $1,091,000 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2020 2020 Q2
Q1 2015 $452,000 $120,000 +$120,000 01 Jan 2015 31 Mar 2015 10-K 10 Jun 2015 2015 FY
Q4 2014 $332,000 $133,000 +$133,000 01 Oct 2014 31 Dec 2014 10-Q 13 Feb 2015 2015 Q3
Q3 2014 $199,000 $133,000 +$133,000 01 Jul 2014 30 Sep 2014 10-Q 13 Nov 2014 2015 Q2
Q2 2014 $66,000 $66,000 +$66,000 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2014 2015 Q1
Q1 2014 $0 $0 01 Jan 2014 31 Mar 2014 10-K 10 Jun 2015 2015 FY
Q4 2013 $0 01 Oct 2013 31 Dec 2013 10-Q 13 Feb 2015 2015 Q3
Q3 2013 $0 01 Jul 2013 30 Sep 2013 10-Q 13 Nov 2014 2015 Q2
Q2 2013 $0 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014 2015 Q1

Pulmatrix, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $511,000 -$443,000 -46% 01 Jan 2024 31 Dec 2024 10-K 21 Mar 2025 2024 FY
2023 $954,000 -$160,000 -14% 01 Jan 2023 31 Dec 2023 10-K 21 Mar 2025 2024 FY
2022 $1,114,000 -$44,000 -3.8% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 $1,158,000 $0 0% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 $1,158,000 -$908,000 -44% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2022 2021 FY
2019 $2,066,000 01 Jan 2019 31 Dec 2019 10-K 23 Mar 2021 2020 FY
2014 $452,000 +$452,000 01 Apr 2014 31 Mar 2015 10-K 10 Jun 2015 2015 FY
2013 $0 01 Apr 2013 31 Mar 2014 10-K 10 Jun 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.